Updated on 1 July 2014
"With the latest diagnostic techniques, a tumor is analyzed and the results of the cancerous status is available to physicians within days. This is certainly helping to offer cure faster to patients," remarked Dr Jeff Allen, executive director, Friends of Cancer Research, a patient advocacy group.
"I never thought I will see the use of immune therapies which are combined with existing targeted therapies in my life time," said Dr Bahija Jallal, executive VP at MedImmune, a unit of AstraZeneca. "Thanks to these combinations some forms of cancer are no longer as dreaded as they used to be few decades ago."
The experts hotly debated some of the new treatment mechanism and ways to speed up development of cancer treatment drugs. One of the suggestion was to let scientists develop new clinical testing techniques which can predict success rate of trials. All the panelists agreed that today cancer drug research takes place in silos with researchers, clinicians and drug developers not sharing and analyzing huge amounts of data generated during the long process.
They noted that using the data analytics tools on the vast databases of data gathered from cancer patients in hospital could be used more efficiently using computer software and generate better understanding and redirection of clinical trials of anti-cancer drugs.